2018 and Beyond: Czech Republic Pharmaceutical and Healthcare Market Trends and Outlook Study to 2025
Spending on medicines and healthcare in Czech Republic witnessed steady growth in 2017, reflecting strong potential for new medicine development, infrastructure building and new entry/ expansion opportunities. Both Pharmaceutical sales and consumption are on rise and the outlook to 2025 remains robust driven by strong pharmaceutical market fundamentals.
The goal of this report is to provide complete strategic analysis and forecast the pharmaceutical industry segments over the near to long term future.
This report focuses its attention on pharmaceutical market in Czech Republic and presents market trends, drivers and challenges facing the R&D professionals, investors, manufacturers, strategists, regulatory and other players. It also presents the pharmaceutical sales of prescription medicines and generic drugs. Further, pharmaceutical imports and exports data is also provided for the country.
The research study on Czech Republic healthcare spending provides outlook of total spending, government expenditure, private expenditure to 2025. Further, the level of out-of-pocket costs borne by patients is also analyzed.
It additionally explores the level and growth of expenditure on healthcare, new drugs and ongoing research studies. The report also considers the Czech Republic healthcare industry prospects and infrastructure detailing hospitals, physicians, bed count, and other facilities. The report also analyzes the disease epidemiology trends through details of leading causes of death.
Through transparent and consistent methodology, the research work provides meaningful evidence based insights into the industry. Further, objective measures are presented in ready to use format, which enables ease of understanding of Czech Republic pharmaceutical market insights and outlook.
The goal of this report is to provide complete strategic analysis and forecast the pharmaceutical industry segments over the near to long term future.
This report focuses its attention on pharmaceutical market in Czech Republic and presents market trends, drivers and challenges facing the R&D professionals, investors, manufacturers, strategists, regulatory and other players. It also presents the pharmaceutical sales of prescription medicines and generic drugs. Further, pharmaceutical imports and exports data is also provided for the country.
The research study on Czech Republic healthcare spending provides outlook of total spending, government expenditure, private expenditure to 2025. Further, the level of out-of-pocket costs borne by patients is also analyzed.
It additionally explores the level and growth of expenditure on healthcare, new drugs and ongoing research studies. The report also considers the Czech Republic healthcare industry prospects and infrastructure detailing hospitals, physicians, bed count, and other facilities. The report also analyzes the disease epidemiology trends through details of leading causes of death.
Through transparent and consistent methodology, the research work provides meaningful evidence based insights into the industry. Further, objective measures are presented in ready to use format, which enables ease of understanding of Czech Republic pharmaceutical market insights and outlook.
1 TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 EXECUTIVE SUMMARY
2.1 Czech Republic Pharmaceutical and Healthcare Industry Snapshot
2.2 Czech Republic Pharmaceuticals Market Overview
3 CZECH REPUBLIC PHARMACEUTICAL MARKET STRATEGIC ANALYSIS REVIEW
3.1 Pharmaceutical Trends in Czech Republic
3.2 Drivers and Restraints
3.2.1 Market Drivers in Czech Republic Pharmaceuticals and Healthcare Industry
3.2.2 Drivers Explained
3.2.3 Market Restraints in Czech Republic Pharmaceuticals and Healthcare Industry
3.2.4 Restraints Explained
4 CZECH REPUBLIC PHARMACEUTICAL MARKET OUTLOOK
4.1 Czech Republic Pharmaceutical Sales, $ Million, 2015- 2025
4.2 Czech Republic Pharmaceutical Exports, $ million, 2015- 2025
4.3 Czech Republic Pharmaceutical Imports, $ Million, 2015- 2025
4.4 Czech Republic (% contribution) to Regional Pharmaceutical Market size, 2017
4.5 Czech Republic (% contribution) to Global Pharmaceutical Market size, 2017
4.6 Czech Republic Prescription Drug Sales, $ Million, 2015- 2025
4.7 Czech Republic Generic Drug Sales, $ Million, 2015- 2025
5 CZECH REPUBLIC HEALTHCARE MARKET OUTLOOK
5.1 Czech Republic Healthcare Expenditure Outlook, 2015- 2025
5.2 Czech Republic Healthcare Expenditure (% of GDP), 2015- 2025
5.3 Czech Republic Government Healthcare Expenditure (% of total expenditure), 2015- 2025
5.4 Czech Republic Private Healthcare Expenditure (% of total expenditure), 2015- 2025
5.5 Out of pocket expenditure (% of total expenditure) in Czech Republic, 2015- 2025
6 CZECH REPUBLIC HEALTHCARE MARKET STATISTICS
6.1 Czech Republic Mortality by Disease Category, 2017
6.2 Number of Hospitals in Czech Republic, 2007- 2017
6.3 Number of Hospital Beds in Czech Republic, 2007- 2017
6.4 Physicians Count in Czech Republic, 2007- 2017
6.5 Pharmacists Count in Czech Republic, 2007- 2017
7 CZECH REPUBLIC CLINICAL TRIALS RESEARCH INDUSTRY
7.1 Total Ongoing Clinical Trials in Czech Republic, 2017
7.2 Ongoing Clinical Trials by Disease Category in Czech Republic, 2017
7.3 Ongoing Clinical Trials by Type, 2017
7.4 Ongoing Clinical Trials by Status, 2017
7.5 Ongoing Clinical Trials by Sponsor Type, 2017
8 CZECH REPUBLIC DEMOGRAPHIC AND MACROECONOMIC PROFILE
8.1 Czech Republic Population Forecast by Age Group, 2005- 2025
8.2 Czech Republic Population Forecast by Location, 2005- 2025
8.3 Czech Republic GDP Forecast, 2005- 2025
8.4 Czech Republic GDP Per Capita Forecast, 2005- 2025
8.5 Czech Republic Disposable Income Forecast, 2005- 2025
9 BUSINESS PROFILES OF LEADING PHARMACEUTICAL COMPANIES
9.1 Johnson and Johnson Pharmaceutical Company Profile
9.2 Bayer Pharmaceutical Company Profile
9.3 Novartis Pharmaceutical Company Profile
9.4 Pfizer Pharmaceutical Company Profile
9.5 Roche Pharmaceutical Company Profile
9.6 Sanofi Pharmaceutical Company Profile
9.7 Merck Pharmaceutical Company Profile
9.8 Gilead Sciences Pharmaceutical Company Profile
9.9 GlaxoSmithKline Pharmaceutical Company Profile
9.10. AstraZeneca Pharmaceutical Company Profile
10 RECENT INDUSTRY DEVELOPMENTS IN CZECH REPUBLIC PHARMACEUTICALS AND HEALTHCARE MARKETS
11 APPENDIX
11.1 About VPA Research
11.2 Sources and Methodology
1.1 List of Tables
1.2 List of Figures
2 EXECUTIVE SUMMARY
2.1 Czech Republic Pharmaceutical and Healthcare Industry Snapshot
2.2 Czech Republic Pharmaceuticals Market Overview
3 CZECH REPUBLIC PHARMACEUTICAL MARKET STRATEGIC ANALYSIS REVIEW
3.1 Pharmaceutical Trends in Czech Republic
3.2 Drivers and Restraints
3.2.1 Market Drivers in Czech Republic Pharmaceuticals and Healthcare Industry
3.2.2 Drivers Explained
3.2.3 Market Restraints in Czech Republic Pharmaceuticals and Healthcare Industry
3.2.4 Restraints Explained
4 CZECH REPUBLIC PHARMACEUTICAL MARKET OUTLOOK
4.1 Czech Republic Pharmaceutical Sales, $ Million, 2015- 2025
4.2 Czech Republic Pharmaceutical Exports, $ million, 2015- 2025
4.3 Czech Republic Pharmaceutical Imports, $ Million, 2015- 2025
4.4 Czech Republic (% contribution) to Regional Pharmaceutical Market size, 2017
4.5 Czech Republic (% contribution) to Global Pharmaceutical Market size, 2017
4.6 Czech Republic Prescription Drug Sales, $ Million, 2015- 2025
4.7 Czech Republic Generic Drug Sales, $ Million, 2015- 2025
5 CZECH REPUBLIC HEALTHCARE MARKET OUTLOOK
5.1 Czech Republic Healthcare Expenditure Outlook, 2015- 2025
5.2 Czech Republic Healthcare Expenditure (% of GDP), 2015- 2025
5.3 Czech Republic Government Healthcare Expenditure (% of total expenditure), 2015- 2025
5.4 Czech Republic Private Healthcare Expenditure (% of total expenditure), 2015- 2025
5.5 Out of pocket expenditure (% of total expenditure) in Czech Republic, 2015- 2025
6 CZECH REPUBLIC HEALTHCARE MARKET STATISTICS
6.1 Czech Republic Mortality by Disease Category, 2017
6.2 Number of Hospitals in Czech Republic, 2007- 2017
6.3 Number of Hospital Beds in Czech Republic, 2007- 2017
6.4 Physicians Count in Czech Republic, 2007- 2017
6.5 Pharmacists Count in Czech Republic, 2007- 2017
7 CZECH REPUBLIC CLINICAL TRIALS RESEARCH INDUSTRY
7.1 Total Ongoing Clinical Trials in Czech Republic, 2017
7.2 Ongoing Clinical Trials by Disease Category in Czech Republic, 2017
7.3 Ongoing Clinical Trials by Type, 2017
7.4 Ongoing Clinical Trials by Status, 2017
7.5 Ongoing Clinical Trials by Sponsor Type, 2017
8 CZECH REPUBLIC DEMOGRAPHIC AND MACROECONOMIC PROFILE
8.1 Czech Republic Population Forecast by Age Group, 2005- 2025
8.2 Czech Republic Population Forecast by Location, 2005- 2025
8.3 Czech Republic GDP Forecast, 2005- 2025
8.4 Czech Republic GDP Per Capita Forecast, 2005- 2025
8.5 Czech Republic Disposable Income Forecast, 2005- 2025
9 BUSINESS PROFILES OF LEADING PHARMACEUTICAL COMPANIES
9.1 Johnson and Johnson Pharmaceutical Company Profile
9.2 Bayer Pharmaceutical Company Profile
9.3 Novartis Pharmaceutical Company Profile
9.4 Pfizer Pharmaceutical Company Profile
9.5 Roche Pharmaceutical Company Profile
9.6 Sanofi Pharmaceutical Company Profile
9.7 Merck Pharmaceutical Company Profile
9.8 Gilead Sciences Pharmaceutical Company Profile
9.9 GlaxoSmithKline Pharmaceutical Company Profile
9.10. AstraZeneca Pharmaceutical Company Profile
10 RECENT INDUSTRY DEVELOPMENTS IN CZECH REPUBLIC PHARMACEUTICALS AND HEALTHCARE MARKETS
11 APPENDIX
11.1 About VPA Research
11.2 Sources and Methodology
